louisiana glp-1 bowel obstruction lawsuit gastric intestinal class action in Victoza [2026 Update] semaglutide bowel obstruction class action

You are solely responsible for determining whether any investment, investment strategy, security or related transaction is appropriate for you based on your personal investment objectives, financial circumstances and risk tolerance

LifeMD can offer you even more guidance on how the program works, how to get started, the benefits of the program, and how to see results

We accept most major medical insurance and will help you understand what your plan covers

Consumers should also watch for red flags indicating problematic products or marketing: companies making pharmaceutical equivalence claims, dramatic before-and-after weight loss promises, proprietary blend language hiding strain disclosure, astronomical CFU counts emphasized without research context, and guarantee windows too short to allow realistic assessment (under 60 days)

If you took one of these medications and developed gastroparesis, intestinal blockage, ileus, or other serious digestive problems, you may have the right to pursue compensation from the manufacturers who failed to adequately warn about these risks

Clinical trials have demonstrated that patients taking semaglutide, marketed as Wegovy for weight loss, lose an average of about 15% of their body weight over approximately 68 weeks when combined with diet and exercise